Davis Polk advised the joint bookrunners in connection with the equity offering by Minerva S.A. and VDQ Holdings S.A., a shareholder of Minerva, of common shares of Minerva for an aggregate…
Davis Polk advised the underwriters in connection with the offering of $3 billion aggregate principal amount of 1.625% U.S. dollar bonds due January 22, 2025, issued by Her Majesty in…
Davis Polk advised the initial purchasers in connection with the offering by Corporación Nacional del Cobre de Chile of $2.0 billion aggregrate principal amount of notes. The offering…
Davis Polk advised the underwriters in connection with the offering of C$750 million aggregate principal amount of 2.65% bonds due February 5, 2025, issued by the Province of Ontario. The…
Davis Polk advised the initial purchasers in connection with the offering by Corporación Nacional del Cobre de Chile of $2 billion aggregrate principal amount of notes. The offering…
Davis Polk advised Banco de Crédito del Perú in connection with offerings of $700 million aggregate principal amount of 2.700% fixed-rate notes due 2025 and S/2.5 billion 4.650% notes due…
Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point Therapeutics, Inc. Turning Point Therapeutics’ common stock is…
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering of common stock by Seattle Genetics, Inc. for gross…
Davis Polk advised the joint book-running managers and initial purchasers in a Rule 144A/Regulation S offering of €195 million principal amount of senior secured notes due 2026 of WMG…
Davis Polk advised the representatives of the several underwriters in connection with a $191.5 million initial public offering of common stock of Turning Point Therapeutics, Inc…